Deals & Corporate Governance
- 
									April 11, 2025
									Dentsply Brass Face Investor Suit Over Alleged Dental InjuriesExecutives and directors of dental supply manufacturing company Dentsply Sirona Inc. have been hit with a derivative suit alleging they concealed that a company subsidiary was approving unsuitable patients for dental treatments to inflate sales figures. 
- 
									April 11, 2025
									NC AG Can't Shield Most Merger Review Docs, Judge HoldsThe North Carolina Attorney General's Office can't shield a host of internal records pertaining to its review of a 2019 hospital merger at the center of a compliance case, a state court judge has said, finding "only a few" records constitute protected attorney-client communications or work product. 
- 
									April 11, 2025
									Aurinia Sues Lotus Alleging Lupus Drug Patent InfringementKidney-focused biotech Aurinia Pharmaceuticals Inc. on Friday launched a lawsuit in New Jersey federal court claiming that Lotus Pharmaceutical Co. Ltd.'s bid to sell a generic form of Aurinia's lupus nephritis treatment Lupkynis infringes a pair of patents. 
- 
									April 11, 2025
									5th Circ. Revives Unfair Competition Fight Over Arthritis DrugThe Fifth Circuit has revived Zyla Life Sciences LLC's lawsuit seeking to block Texas rival Wells Pharma from selling rheumatoid arthritis drug suppositories that aren't U.S. Food and Drug Administration-approved, rejecting Wells Pharma's argument that Zyla's state claims are preempted under federal law and noting that finding otherwise would have "staggering" implications. 
- 
									April 11, 2025
									Future Pak Goes Public With $255M Theratechnologies BidPharmaceutical manufacturer and packager Future Pak LLC, advised by Honigman LLP, on Friday publicly unveiled its proposal to acquire pharmaceutical company Theratechnologies Inc. for up to $255 million, a move that comes after Future Pak has received "minimal engagement" from the other company. 
- 
									April 08, 2025
									Iowa Hospital's Decline Gets Close Look In Bankruptcy CaseThe former operator of a now-bankrupt Iowa hospital is facing scrutiny over allegations the hospital suffered massive operating losses while paying some $9 million to the operator in fees in the years before its financial collapse. 
- 
									April 08, 2025
									Healthcare IPOs Take Another Hit Amid Trump Tariff WarHopes for an improving healthcare public market all but vanished after a sweeping tariffs announcement from Washington set off a wave of market volatility. 
- 
									April 08, 2025
									Pacira Reaches IP Deal Allowing Generic Painkiller In 2030Pacira BioSciences has agreed to settle a series of patent infringement lawsuits against Fresenius Kabi and other pharmaceutical companies over Pacira's drug Exparel, a long-acting injectable for managing postsurgical pain. 
- 
									April 08, 2025
									Hospital Operator Gets 'Burdensome' Antitrust Info Bid ParedA North Carolina federal judge has pared HCA Healthcare Inc.'s subpoenas to a hospital network in a consolidated antitrust case accusing it of hiking Tar Heel State public employees' health insurance costs, putting a two-hour time limit on the depositions it sought and cutting three years of requested information. 
- 
									April 08, 2025
									Pharmaceutical Tariff Exemption Is No End to Cost ThreatThe life sciences industry escaped much of the immediate impact of President Donald Trump's market-shaking tariff order, thanks to the inclusion of a single word on an exemption list — "pharmaceuticals." The relief may not last long. 
- 
									April 08, 2025
									Facing Private Equity Pressures, Doctors Head Back To SchoolAs private equity continues to reach into the healthcare space, some doctors are joining physician-focused MBA programs, honing new skills to better compete in a rapidly changing business. 
- 
									April 08, 2025
									Longtime Cooley Life Sciences Ace Jumps To Wilson SonsiniWilson Sonsini Goodrich & Rosati PC has hired a former Cooley LLP partner for its corporate department to strengthen the services offered by its life sciences practice, it announced on Tuesday. 
- 
									April 08, 2025
									Amedisys Gets Merger Filing Claim Paused In DOJ's UHG SuitA Maryland federal judge has hit pause on part of the Justice Department lawsuit challenging UnitedHealth's $3.3 billion acquisition of home health and hospice company Amedisys, preferring to handle the merger challenge first and only then turn to allegations that Amedisys shirked its merger filing requirements. 
- 
									April 07, 2025
									Torrent Seeks Arbitration In Drug Commercialization FightA subsidiary of Indian multinational company Torrent Pharmaceuticals is urging a Delaware judge to force OWP Pharmaceuticals to arbitrate a dispute over issues that allegedly delayed the U.S. commercialization of its epilepsy and anti-seizure medications. 
- 
									April 07, 2025
									Incyte Can't Get Pretrial Win In Novartis Royalty FightA New York federal judge has disagreed with Incyte Corp.'s argument that its interpretation of a drug commercialization contract at the heart of a royalties dispute with Novartis Pharma AG is the right one, ahead of a jury trial scheduled next month. 
- 
									April 07, 2025
									Conn. Judge Pauses 'Staggering' Hospital Data SubpoenaA Connecticut judge temporarily paused a subpoena seeking what a health nonprofit called "a staggering amount" of confidential patient data by a proposed class of Constitution State residents accusing Hartford HealthCare Corp. of monopolizing the state's healthcare industry, stating that the court must review the subpoena first. 
- 
									April 07, 2025
									NC Doctors Say Fee-Sharing Row Resulted In Pay CutsA group of North Carolina anesthesiologists accused their business partners of slashing their monthly compensation in half in retaliation against them for questioning a proposed fee-sharing arrangement, saying the cut allegedly violated the doctors' contracts and breached the partners' fiduciary duty. 
- 
									April 03, 2025
									Compounders Say Shortage Of Weight Loss Drug ContinuesA group of compounding pharmacies looking to keep producing copycat doses of Eli Lilly & Co's lucrative weight loss drug tirzepatide are telling a Texas federal judge that demand for the drug has "far outpaced" supply despite the Food and Drug Administration declaring the medication's shortage over last year, a move that removed their right to make compounded versions. 
- 
									April 03, 2025
									Amazon, Biotech Net $1.9M Win Against Fake Supplement SellersA Washington federal judge has awarded biotechnology company Quincy Biosciences and Amazon a combined total of $1,895,375.40 in default judgments against several individuals who hawked counterfeit Prevagen brain health products through Amazon's marketplace, after the sellers failed to appear or participate in the case. 
- 
									April 02, 2025
									Serial Acquisitions Are Still On The FTC's RadarThe previous administration's focus on private equity firms making serial acquisitions in the same industry may continue under the Federal Trade Commission's new leadership, an agency official said Wednesday. 
- 
									April 02, 2025
									PE Firm TPG Wants Endo Trust's Transfer Suit TossedPrivate equity firm TPG Capital is seeking the dismissal of a lawsuit that aims to claw back billions of dollars reaped in an allegedly unfair deal with Endo International PLC before the drugmaker went bankrupt. 
- 
									April 02, 2025
									Healthcare REIT Lands $140M Senior Living Mortgage LoanDiversified Healthcare Trust borrowed a three-year, nonrecourse $140 million loan secured by a portfolio of senior living communities, the healthcare-focused real estate investment trust announced. 
- 
									April 01, 2025
									Two More Pharmacies Hit With Eli Lilly Weight Loss Drug SuitsEli Lilly and Co. filed another round of lawsuits Tuesday accusing compounding pharmacies of selling copycat versions of its weight loss and diabetes medications, saying in New Jersey and Delaware federal courts that two online pharmacies are deceiving consumers about their knockoff products. 
- 
									April 01, 2025
									Forecast For Health Startups Shows Bright Spots Amid GloomRaising investor cash has been challenging for earlier-stage healthcare and life sciences startups over the past few years. But a smattering of private startups in recent weeks has shown that fundraising is still possible despite tough circumstances. 
- 
									April 01, 2025
									FDA Cuts Prompt Biotech Players To Rethink Deal StrategiesFunding cuts at the U.S. Department of Health and Human Services are sending ripples of concern through the biotech industry, as attorneys advise companies to consider a wider breadth of strategic alternatives amid fears of regulatory delays. 
Expert Analysis
- 
								
								Private Equity Owners Can Remedy Law Firms' Agency Issues  Nonlawyer, private-equity ownership of law firms can benefit shareholders and others vulnerable to governance issues such as disparate interests, and can in turn help resolve agency problems, says Michael Di Gennaro at The Law Practice Exchange. 
- 
								
								How To Protect Atty-Client Privilege While Using Generative AI  When using generative artificial intelligence tools, attorneys should consider several safeguards to avoid breaches or complications in attorney-client privilege, say Antonious Sadek and Christopher Campbell at DLA Piper. 
- 
								
								How New Lawyers Can Leverage Feedback For Growth  Embracing constructive criticism as a tool for success can help new lawyers accelerate their professional growth and law firms build a culture of continuous improvement, says Katie Aldrich at Fringe Professional Development. 
- 
								
								State Privacy Laws: Not As Comprehensive As You May Think  As more U.S. states enact privacy laws, companies must be aware that these laws vary in scope and content, meaning organizations should take a stringent approach to compliance by considering notice, choice and data security obligations, among other requirements, says Liisa Thomas at Sheppard Mullin. 
- 
								
								ESG Around The World: Australia  Clive Cachia and Cathy Ma at K&L Gates detail ESG-reporting policies in Australia and explain how the country is starting to introduce mandatory requirements as ESG performance is increasingly seen as a key investment and corporate differentiator in the fight for global capital. 
- 
								
								Address The Data Monopoly, Otherwise Tech Giants Control AI.jpg)  It is likely that we will experience a severe monopoly on artificial intelligence systems and patents by the largest players in the tech industry, so the way we treat data needs to change, whether through the legislature, the courts or tech companies, says Pranav Katti at Barclay Damon. 
- 
								
								Info Exchanges Must Stay Inside Now-Invisible Antitrust Lines  While the antitrust agencies recently withdrew long-standing enforcement policy statements for being "overly permissive" on information exchanges, we should not assume that all information exchanges are inherently suspect — they are still permissible if carefully constructed and vigorously managed, say attorneys at Nelson Mullins. 
- 
								
								Twitter Legal Fees Suit Offers Crash Course In Billing Ethics  X Corp.'s suit alleging that Wachtell grossly inflated its fees in the final days of Elon Musk’s Twitter acquisition provides a case study in how firms should protect their reputations by hewing to ethical billing practices and the high standards for professional conduct that govern attorney-client relationships, says Lourdes Fuentes at Karta Legal. 
- 
								
								Amgen-Horizon Deal May Signal FTC's Return To Bargaining  The Federal Trade Commission's recent settlement of its challenge to Amgen's proposed acquisition of Horizon Therapeutics marks the latest in a string of midlitigation settlements, and may signal that competition regulators are more inclined toward such negotiations following recent litigation losses, say attorneys at Freshfields. 
- 
								
								ABA's Money-Laundering Resolution Is A Balancing Act  While the American Bar Association’s recently passed resolution recognizes a lawyer's duty to discontinue representation that could facilitate money laundering and other fraudulent activity, it preserves, at least for now, the delicate balance of judicial, state-based regulation of the legal profession and the sanctity of the attorney-client relationship, say attorneys at Ballard Spahr. 
- 
								
								FTC Settlements Widen Efforts To Shield Health Data  The Federal Trade Commission's recent enforcement actions aim to send a clear message that companies using tracking technologies should carefully monitor the sharing of sensitive data, particularly in the mental health, substance use disorder treatment and reproductive health care fields, say attorneys at Choate. 
- 
								
								Law Firm Professional Development Steps To Thrive In AI Era  As generative artificial intelligence tools rapidly evolve, professional development leaders are instrumental in preparing law firms for the paradigm shifts ahead, and should consider three strategies to help empower legal talent with the skills required to succeed in an increasingly complex technological landscape, say Steve Gluckman and Anusia Gillespie at SkillBurst Interactive. 
- 
								
								HHS Neuromonitoring Advisory May Have Broad Relevance  The Health Department Office of Inspector General's recent advisory opinion rejecting a neuromonitoring service's proposal for a shell arrangement isn't surprising, but it could be a harbinger of more warnings against problematic joint venture arrangements to come, says Mary Kohler at Kohler Health Law.